Two long-acting insulin analogs have been developed for use as "basal" components of insulin treatment regimens: glargine and detemir. (Insulin glargine has US Food and Drug Administration [FDA] ...
Purpose: The pharmacology, pharmacokinetics, efficacy and tolerability, safety, drug interactions, dosage and administration, cost, and place in therapy of insulin detemir are reviewed. Summary: ...
Please provide your email address to receive an email when new articles are posted on . Women with type 1 diabetes who used insulin degludec during pregnancy had similar HbA1c and glucose profile as ...
MISSISSAUGA, ON, Oct. 18, 2013 /CNW/ - Novo Nordisk today announced that Health Canada has approved Levemir® FlexTouch®, a disposable prefilled insulin pen containing Levemir® (insulin detemir).
The Practice Point commentary published in the September 2008 issue contained two numerical errors. The total daily dose of once-daily insulin detemir cited in the commentary was 0.78IU/kg. This was, ...
Novo Nordisk will no longer be manufacturing Levemir ® (insulin detemir [rDNA origin] injection), according to a discontinuation notice posted by the Company. Levemir is a long-acting human insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results